Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoyuan Li

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Bioactive Materials|September 20, 2021
Additively manufactured biodegradable porous magnesium implants for elimination of implant-related infections: An <i>in vitro</i> and <i>in vivo</i> studyKai Xie, Nanqing Wang, Yu Guo, et al.
Acta Biomaterialia|December 31, 2023
Fully integrated wearable microneedle biosensing platform for wide-range and real-time continuous glucose monitoringLei Li, Yujie Zhou, Chenwei Sun, et al.
Oncotargets and Therapy|August 26, 2021
Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II StudyDengfeng Ren, Guoxiu Wang, Yu Zhang, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Bioactive Materials|September 20, 2021
Additively manufactured biodegradable porous magnesium implants for elimination of implant-related infections: An <i>in vitro</i> and <i>in vivo</i> studyKai Xie, Nanqing Wang, Yu Guo, et al.
Acta Biomaterialia|December 31, 2023
Fully integrated wearable microneedle biosensing platform for wide-range and real-time continuous glucose monitoringLei Li, Yujie Zhou, Chenwei Sun, et al.
Oncotargets and Therapy|August 26, 2021
Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II StudyDengfeng Ren, Guoxiu Wang, Yu Zhang, et al.
Pageof 6